40
In band
Moving averages
SMA 200$11.41-34.18%
Company profile
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune and inflammatory diseases. The company is headquartered in New York, New York.
SectorHealthcare
IndustryBiotechnology
Market cap$108.47M
P/E ratioNone
EPS$-3.83
Beta1.452
Dividend yield0.00%
52-week high$17.43
52-week low$5.06
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
SAVA
Cassava Sciences Inc
NERV
Minerva Neurosciences Inc
RSI 32
CGTX
Cognition Therapeutics Inc
RSI 32
HRTX
Heron Therapeutics Inc
RSI 37
CHRS
Coherus Biosciences Inc
RSI 34
DTIL
Precision Biosciences Inc
RSI 56
RSI alerts for IMUX
An email when IMUX closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:13 PM EDT